Relations between n-3 fatty acid status and cardiovascular disease risk factors among Quebecers

American Journal of Clinical Nutrition

Volumn 74, Issue 5, 2001, Pages 603-611

  Dewailly, Éric ^a   Blanchet, Carole ^b   Gingras, Suzanne ^b   Lemieux, Simone ^b   Sauvé, Louise ^b   Bergeron, Jean ^b   Holub, Bruce John ^b  

^a UNIVERSITÉ LAVAL   (Canada)

^b NONE

Author keywords

Blood pressure; Cardiovascular disease risk factor; Cholesterol; Docosahexaenoic acid; Eicosapentaenoic acid; Fish intake; Glucose; HDL; Insulin; LDL; n 3 Fatty acids; Quebec; Triacylglycerol

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; PHOSPHOLIPID; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CANADA; CARDIOVASCULAR DISEASE; CONCENTRATION RESPONSE; CORRELATION FUNCTION; DIASTOLIC BLOOD PRESSURE; DIETARY INTAKE; DISEASE ASSOCIATION; FEMALE; FISH; GLUCOSE BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

EID: 0034751017     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/74.5.603     Document Type: Article

References (74)

1. Stratifying the patient at risk from coronary disease: New insights from the Framingham heart study
2. Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults-the evidence report
3. Abdominal obesity and the risk of coronary artery disease
4. Linolenate-derived polyunsaturated fatty acids and prevention of atherosclerosis
5. Dietary fish oils containing eicosapentaenoic acid and the prevention of atherosclerosis and thrombosis
6. Fish oils and plasma lipid and lipoprotein metabolism in humans: A critical review
7. Cardiovascular effects of n-3 fatty acids
8. n-3 polyunsaturated fatty acids: Update 1995
9. Omega-3 fatty acids in the prevention-management of cardiovascular disease
10. The composition of food consumed by Greenland Eskimos
11. Eicos-apentanoic acid and prevention of thrombosis and atherosclerosis
12. Eicosapentaenoic acids and platelet function in Japanese
13. Eicosapolyenoic acids of serum lipids of Japanese islanders with low incidence of cardiovascular diseases
14. The inverse relation between fish consumption and 20-year mortality from coronary heart disease
15. Fish consumption and risk of stroke: The Zutphen study
16. Fish consumption and risk of sudden cardiac death
17. Effect of serum fatty acid composition on coronary atherosclerosis in Japan
18. Fish consumption and coronary heart disease mortality in Finland, Italy, and the Netherlands
19. Effects of changes in fat, fish and fibre intakes on death and myocardial reinfarction: Diet and reinfarction trial (DART)
20. Fish con-sumption and mortality from coronary heart disease
21. Effect of garlic and fish-oil supplementation on serum lipid and lipoprotein concentrations in hypercholesterolemic men
22. Omega-3 fatty acids and cardiovascular risk factors
23. Effects of a fish oil supplement on serum lipids, blood pressure, bleeding time, haemostatic and rheological variables. A double blind randomised controlled trial in healthy volunteers
24. Blood pressure-and lipid-lowering effect of mackerel and herring diet in patients with mild essential hypertension
25. Fatty acids, triglycerides and syndromes of insulin resistance
26. Fatty acid composition of the plasma lipids in Greenland Eskimos
27. Clinical and epidemiological studies of eicosapentaenoic acid in Japan
28. Et votre coeur, ça va?
29. Canadian heart health surveys: A profile of cardiovascular risk. Survey methods and data analysis
30. Hyperinsulinemia as an independant risk factor for ischemic heart disease
31. Alterations in molecular species of cholesterol esters formed via plasma lecithin-cholesterol acyltransferase in human subjects consuming fish oil
32. Report of the Canadian Hypertension Society's consensus conference on the management of mild hypertension
33. A single threshold value of waist girth identifies normal-weight and overweight subjects with excess visceral adipose tissue
34. Regional distribution of body fat, plasma lipoproteins, and cardio-vascular disease
35. Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardio-vascular risk in men and women
36. Contribution of selected traditional and market food to Nunavik Inuit women diet
37. Polyunsaturated fatty acids in the food chain in Japan
38. Polyunsaturated fatty acids in the food chain in the United States
39. Serum fatty acids and fish intake in rural Japanese, urban Japanese, Japanese American and Caucasian American men
40. Population-based comparative study on dietary habits and serum fatty acid compositions
41. Usefulness of plasma phospholipid n-3 fatty acid levels in predict-ing dietary fish intake in patients with coronary artery disease
42. Potential health benefits of the omega-3 fatty acids in fish
43. Fish consumption and cardiovascular mortality in Canada: An inter-regional comparison
44. Fish oil and cardiovascular disease: Lipids and arterial function
45. Weighing contaminant risks and nutrient benefits of country food in Nunavik
46. Divergent lipoprotein responses to fish oils with various ratios of eicosapentaenoic acid and docosa-hexaenoic acid
47. Omega-3 fatty acids in health and disease and in growth and development
48. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in midly hyper-lipidemic men
49. Triglyceride-lowering effect of omega-3 LC-polyunsaturated fatty acids - A review
50. Effects of docosahexaenoic acid on serum lipoproteins in patients with combined hyperlipidemia: A randomized, double-blind, placebo-controlled trial
51. Erythrocyte eicosapentaenoic acid versus docosahexaenoic acid as a marker for fish and fish oil consumption
52. Habitual fish consumption, plasma phospholipid fatty acids, and serum lipids: The Tromso study
53. The effect of dietary-3 fatty acids on coronary atherosclerosis. A ran-domized, double-blind, placebo-controlled trial
54. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial
55. Serum fatty acids and the risk of coronary heart disease
56. Does fish oil lower blood pressure? A meta-analysis of controlled trials
57. Fatty acids and hypertension
58. Fish oil and glycemic control in diabetes. A meta-analysis
59. Fatty acids and diabetes mellitus
60. Elevated plasma glucose and lowered triglyceride levels from omega-3 fatty acid supplementation in type II diabetes
61. Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM
62. One-year treatment with ethyl esters of n-3 fatty acids in patients with hypertriglyceridemia and glucose intolerance: Reduced triglyceridemia, total cholesterol and increased HDL-C without glycemic alterations
63. Effects of a small quantity of n-3 fatty acids on cardiovascular risk factors in NIDDM
64. Dietary supplementation with n-3 fatty acids increases gluconeogenesis from glycerol but not hepatic glucose production in patients with non-insulin-dependent diabetes mellitus
65. Essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids